The global clinical decision support systems market size is anticipated to reach USD 10.71 billion by 2030 and is projected to grow at a CAGR of 10.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.

During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.

Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.

Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions. 

Clinical Decision Support Systems Market Report Highlights

• Based on product, the standalone CDSS segment led the market with the largest revenue share of 30.85% in 2023, owing to its low cost. The segment is estimated to hold approximately 31.0% of the overall market by 2030
• Based on application, the drug allergy alerts segment led the market with the largest revenue share of 25.83% in 2023, owing to the rising burden of allergies
• Based on delivery mode, the on-premises segment held the market with the largest revenue share of 42.35% in 2023, owing to its high adoption rate by healthcare organizations
• Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023, owing to high frequency of updating software and other maintenance services
• North America dominated the market with the revenue share of 43.76% in 2023, due to strong presence of market player and increasing government initiatives to promote efficient usage of clinical decision support tools

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global biohacking market size was valued at USD 20.94 billion in 2023 and is projected to grow at a CAGR of 18.6% from 2024 to 2030. Factors expected to drive the growth of the biohacking market are the availability of wearable health trackers, genetic testing kits, smart devices, and apps that allow people to track and analyze their biometric data, leading to a more personalized and data-focused biohacking approach.
• The global digital neuro biomarkers market size was estimated at USD 593.1 million in 2023 and is projected to grow at a CAGR of 25.3% from 2024 to 2030. The market is experiencing significant growth, driven by several key factors that reflect the increasing integration of technology in healthcare. These factors include the rising prevalence of chronic diseases, technological advancements, increased adoption of remote patient monitoring, growing focus on personalized medicine, and investment in research and development.

Clinical Decision Support Systems Market Segmentation

Grand View Research has segmented the global clinical decision support systems market report based on product, application, delivery mode, component, and region:

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standalone CDSS
• Integrated CPOE with CDSS
• Integrated EHR with CDSS
• Integrated CDSS with CPOE & EHR

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug-drug interactions
• Drug allergy alerts
• Clinical reminders
• Clinical guidelines
• Drug dosing support
• Others

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Web-based Systems
• Cloud-based Systems
• On-premise Systems

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware
• Software
• Services

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Italy
• Spain
• France
• Sweden
• Denmark
• Norway
• Asia Pacific
• China
• India
• Japan
• Thailand
• South Korea
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Order a free sample PDF of the Clinical Decision Support Systems Market Intelligence Study, published by Grand View Research.